Modelling and Economic Evaluation of Vaccines group
We are a group of mathematical modellers and health economists based at LSHTM and Public Health England who conduct applied epidemiological and economic research to inform public health decisions about vaccination.
We also work closely with a wider group of researchers interested in vaccines, including epidemiologists, biostatisticians, social science researchers, computer scientists and clinicians.
Our work has three foci:
- Conducting UK-based research in collaboration with Public Health England to inform recommendations by the Joint Committee on Vaccines and Immunisation (JCVI) and other key stakeholders.
- Conducting research to inform funding decisions and global recommendations by international organisations including WHO; Gavi, the Vaccine Alliance and BMGF.
- Conducting research to support vaccine decision-making in countries across the world, including high-, middle- and low-income countries. Our country-based work is always done in collaboration with local researchers and stakeholders.
MEEV members are part of the NIHR Global Health Research Group on the Evidence to Policy pathway for Immunisation in China (NIHR EPIC), the NIHR Health Protection Research Unit on Immunisation and the Vaccine Impact Modelling Consortium.
We are closely linked with both the Centre for Mathematical Modelling of Infectious Diseases and the Vaccine Centre at LSHTM.
We collaborate closely with other groups active in vaccine-related research including the:
- Modelling and Economics Unit, Centre of Infectious Disease Surveillance and Control, and Viral Reference Laboratory at Public Health England
- Centre for Health Economics Research and Modelling of Infectious Diseases (CHERMID) of the University of Antwerp
- Brisson lab at the University of Laval
- School of Public Health at the University of Hong Kong
- Saw Swee Hock School of Public Health (SSHSPH) at the National University of Singapore
- Newall lab at the University of New South Wales
- Yu lab at Fudan University
- Health Intervenion and Technology Assessment Program in Thailand
- University of Cambridge
- Biocomplexity Institute of Virginia Tech
We are interested in opportunities to explore new collaborations with researchers and decision makers on epidemiological and economic analyses to inform decision making about vaccination policy in any setting.